Медицинская литература. Новинки

 

 

 

 

 

 

ТИРЕОТРОПИНОМА: ТРУДНОСТИ ДИФФЕРЕНЦИАЛЬНОЙ ДИАГНОСТИКИ (Клинический случай)

Вы можете загрузить полный текст статьи в формате pdf

Тиреотропинома – одна из редких причин развития тиреотоксикоза. Ошибки в дифференциальной диагностике с другими причинами тиреотоксикоза ведут к необоснованному проведению хирургического вмешательства на щитовидной железе или радиойодтерапии. В статье представлены современные данные об особенностях патогенеза, диагностики, дифференциальной диагностики и лечения ТТГ-секретирующих аденом; описан клинический случай тиреотропиномы у молодой женщины.

Ключевые слова:
тиреотропинома, тиреотоксикоз, аденома гипофиза.

Литература:
1. Кадашев Б.А., Астафьева Л.И. Аденомы гипофиза. Тверь,
2007. С. 152–155.
2. Ando S., Sarlis N.J., Krishan J. et al. Abberant alternative splicing
of thyroid hormone receptor in a TSHsecreting pituitary tumor
is a mechanism for hormone resistance // Mol. Endocr. 2001.
V. 15. P. 1529.
3. Ando S., Sarlis N.J., Oldfield E.H., Yen P.M. Somatic mutation of
TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor // J. Clin. Endocr. Met. 2001. V. 86. P. 5572.
4. Baur A., Buchfelder M., Kohrle J. Expression of 5'-deiodinase
enzymes in normal pituitaries and in various human pituitary adenomas // Eur. J. Endocr. 2002. V. 147. P. 263.
5. BeckPeccos P., BruekerDavis F., Persani L. et al. Thyrotropinsecreting pituitary tumors // Endocr. Rev. 1996. V. 17. P. 610.
6. BeckPeccoz P., Persani L. TSHinduced hyperthyroidism caused
by a pituitary tumor. Nat .Clin. Pract. Endocrinol. Metab. 2006. V.
2 (9). P. 524–528.
7. BeckPeccos P., Roncoroni R., Mariotti S. et al. Sex hormone-binding globulin measurement in patients with inappropriate secretion
of thyrotropin (1ST): evidence against selective pituitary thyroid
hormone resistance in non-neoplastic 1ST // J. Clin. Endocr. Met.
1990. V. 71. P. 19.
8. Chanson P., Weintraub B.D., Harris A.G. Octreotide therapy for
thyroid stimulating hormone-secreting pituitary adenomas: A follow up of 52 patients // Ann. Intern. Med. 1993. V. 119. P. 236.
9. Chatterjee V.K.K., CliftonBright R.J., Gurnell M. Thyroid hormone
resistance. In: Jameson JL, ed: Contemporary Endocrinology:
Hormone Resistance Syndromes. Totowa. Humana Press, 1999.
Р. 145–153
10. Dong Q., BruckerDavis F., Weintraub B.D. et al. Screening of candidate oncogenes in human thyrotropin tumors: absence of activating mutations of the Gall, Gas, or thyrotropin-releasing hormone receptor genes // J. Clin. Endocr. Met. 1996. V. 81. P. 1134.
11. Gesundheit N., Petrick P., Nissim M. et al. Thyrotropin-secreting
pituitary adenomas: clinical and biochemical heterogeneity // An.
Intern. Med. 1989. V. 111. P. 827.
12. Ghannam N.N., Hammami M.M., Muttair Z. et al. Primary
hypothyroidism – associated TSH-secreting pituitary
adenoma/hyperplasia presenting as a bleeding nasal mass and
extremely elevated TSH level // J. Endocr. Invest. 1999. V. 22.
P. 419.
13. Hamilton C., Adams L.C., Maloof F. Hyperthyroidism due to thyrotropin-producing pituitary chromophobe adenoma // N. Engl. J.
Med. 1970. V. 283. P. 1077.
14. Jailer J.W., Holub D.A. Remission of Graves' disease following
radiotherapy of a pituitary neoplasm // Am. J. Med. 1960. V. 28.
P. 497.
15. Losa M., Magnani P., Mortini P. et al. Indium-Ill pentetreotide single-photon emission tomography in patients with TSHecreting
pituitary adenomas: correlation with the effect of a single administration of octreotide on cerum TSH levels // Eur. J. Nucl. Med.
1997. V. 24. P. 728.
16. Mindermann Т., Wilson C.B. Thyrotropin-producing pituitary adenomas // J. Neurosurg. 1993. V. 79. P. 521.
17. Mixson A.J., friedman T.C., David A.K. et al. Thyrotropin-secreting pituitary carcinoma // J. Clin. Endocr. Met. 1993. V. 76.
P. 529.
18. Nabarro J.D.N. Acromegaly // Clin. Endocr. 1987. V. 26. P. 481.
19. Persani L., Preziati D., Matthews C.H. et al. Serum levels of carboxytermi-nal cross-linked telopeptide of type I collagen (ICTP)
in the differential diagno-sis of the syndromes of inappropriate
secretion of TSH // Clin. Endocr. 1997. V. 47. P. 207.
20. Sanno N., Teramoto A., Matsuno A. et al. Clinical and immunohisto-chemical studies on TSH-secreting pituitary adenoma: its multihormonality and expression of Pit-1 // Mod. Pathol. 1994. V. 7.
P. 893.
21. Smallridge R.C. Metabolic, physiologic and clinical indexes of thy
roid function. Werner and Ingbar's The Thyroid. 7th ed.
Philadelphia: Lippincott, 1996. P. 397.
22. Tannahill L.A., Visser T.J., McCabe C.J. et al. Disregulation of
iodothyronine deiodinase enzyme expression and function in
human pituitary tumors // Clin. Endocr. 2002. V. 56. P. 735.
23. Terzolo M., Orlandi F., Basseti M. et al. Hyperthyroidism due to a
pituitary adenoma composed of two different cell types, one secreting alphasubunit alone and another cosecreting alpha-subunit and
thyrotropin // J. Clin. Endocr. Met. 1991. V. 72. P. 415.
24. Yamakita N., Ikeda Т., Murai T. et al. Thyrotropin-producing
pituitary adenoma discovered as a pituitary incidentaloma. Intern
Med. 1995. V. 34 (11). P. 1055–1060.

Thyrotropin-producing adenoma: diagnostic challenges (Сase report

Pituitary thyrotropinproducing adenomas (TSH-omas) are rare tumors that cause hyperthyroidism. Failure to recognize this disease may result in dramatic consequences, such as improper thyroid ablation in patients with central hyper-thyroidism. This article concerns the current issues of pathogenesis, diagnostics, differential diagnostics and treatment of TSH-omas. It also describes a case study of a young woman with thyrotropinproducing adenoma

Keywords:
thyrotropinproducing adenoma, thyrotoxicosis, syndrome of resistance to thyroid hormone